Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Silvia Di Nuzzo, Francesca Mastrostefano, Marzia Soligo, Tasnim Mohamed, Veronica Bonalume, Eleonora De Santis, Francesca Grassi, Valentina Ferretti, Ada Maria Tata, Valerio Magnaghi, Maria Egle De Stefano
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Role of neuregulins in glial cell development
10.1002/(sici)1098-1136(20000115)29:2<104::aid-glia2>3.0.co;2-2 · 2000
Advances in sciatic nerve regeneration: a review of contemporary techniques
10.1016/j.reth.2025.04.016 · 2025
Perisynaptic Schwann cells - the multitasking cells at the developing neuromuscular junctions
10.1016/j.semcdb.2020.02.011 · 2020
Functional regeneration in the hindlimb skeletal muscle of the mdx mouse
10.1007/bf01738755 · 1988
Myelination is delayed during postnatal brain development in the mdx mouse model of Duchenne muscular dystrophy
10.1186/s12868-017-0381-0 · 2017
Truncated dystrophins can influence neuromuscular synapse structure
10.1016/j.mcn.2008.12.011 · 2009
Function and genetics of dystrophin and dystrophin-related proteins in muscle
10.1152/physrev.00028.2001 · 2002
Nerve excitability changes after intravenous immunoglobulin infusions in multifocal motor neuropathy and chronic inflammatory demyelinating neuropathy
10.1016/j.jns.2010.02.002 · 2010
Axonal GABAA stabilizes excitability in unmyelinated sensory axons secondary to NKCC1 activity
10.1113/jp279664 · 2021
Threshold tracking techniques in the study of human peripheral nerve
10.1002/(sici)1097-4598(199802)21:2<137::aid-mus1>3.0.co;2-c · 1998
Role of gelatinases in pathological and physiological processes involving the dystrophin-glycoprotein complex
10.1016/j.matbio.2015.02.005 · 2015
Absence of dystrophin-related protein-2 disrupts Cajal bands in a patient with Charcot-Marie-tooth disease
10.1016/j.nmd.2015.07.001 · 2015
Excitability of human axons
10.1016/s1388-2457(01)00595-8 · 2001
An alternative dystrophin transcript specific to peripheral nerve
10.1038/ng0593-77 · 1993
Expression of neuregulins and their putative receptors, ErbB2 and ErbB3, is induced during Wallerian degeneration
10.1523/jneurosci.17-05-01642.1997 · 1997
Schwann cell development, maturation and regeneration: A focus on classic and emerging intracellular signaling pathways
10.4103/1673-5374.211172 · 2017
Regulation of matrix metalloproteinase-9 (MMP-9) in TNF-stimulated neutrophils: novel pathways for tertiary granule release
10.1189/jlb.0605353 · 2006
Proteolytic cleavage, trafficking, and functions of nuclear receptor tyrosine kinases
10.1111/febs.13342 · 2015
A G+1-->A transversion at the 5′ splice site of intron 69 of the dystrophin gene causing the absence of peripheral nerve Dp116 and severe clinical involvement in a DMD patient
10.1093/hmg/4.11.2171 · 1995
GABA and its B-receptor are present at the node of Ranvier in a small population of sensory fibers, implicating a role in myelination
10.1002/jnr.23489 · 2015
MMP2-9 cleavage of dystroglycan alters the size and molecular composition of Schwann cell domains
10.1523/jneurosci.0141-11.2011 · 2011
Elevated levels of active matrix metalloproteinase-9 cause hypertrophy in skeletal muscle of normal and dystrophin-deficient mdx mice
10.1093/hmg/ddr362 · 2011
Persistent inflammation and nutritional status in Duchenne muscular dystrophy
10.1016/j.clnesp.2024.04.014 · 2024
Dystrophin and its isoforms in a sympathetic ganglion of normal and dystrophic mdx mice: immunolocalization by electron microscopy and biochemical characterization
10.1016/s0306-4522(97)00003-1 · 1997
Synaptic alterations as a neurodevelopmental trait of Duchenne muscular dystrophy
10.1016/j.nbd.2022.105718 · 2022
Motor axonopathies in a mouse model of Duchenne muscular dystrophy
10.1038/s41598-020-65824-1 · 2020
Duchenne muscular dystrophy
10.1038/s41572-021-00248-3 · 2021
Imbalance of NRG1-ERBB2/3 signalling underlies altered myelination in Charcot-Marie-tooth disease 4H
10.1093/brain/awac402 · 2023
Comparative localization of two forms of glutamic acid decarboxylase and their mRNAs in rat brain supports the concept of functional differences between the forms
10.1523/jneurosci.14-03-01834.1994 · 1994
Matrix metalloproteinases: evolution, gene regulation and functional analysis in mouse models
10.1016/j.bbamcr.2009.07.004 · 2010
Schwann-like adult stem cells derived from bone marrow and adipose tissue express γ-aminobutyric acid type B receptors
10.1002/jnr.22652 · 2011
Deletion of GABA-B receptor in Schwann cells regulates Remak bundles and small nociceptive C-fibers
10.1002/glia.22625 · 2014
GABA-B1 receptor-null Schwann cells exhibit compromised in vitro myelination
10.1007/s12035-018-1158-x · 2019
Activation and localization of matrix metalloproteinase-2 and -9 in the skeletal muscle of the muscular dystrophy dog (CXMDJ)
10.1186/1471-2474-8-54 · 2007
A dual role of erbB2 in myelination and in expansion of the Schwann cell precursor pool
10.1083/jcb.148.5.1035 · 2000
Neuregulin, a factor with many functions in the life of a Schwann cell
10.1002/1521-1878(200011)22:11<987::aid-bies5>3.0.co;2-5 · 2000
The classification of nerve fibers
1941
Multiple measures of axonal excitability in peripheral sensory nerves: an in vivo rat model
10.1002/mus.20851 · 2007
Impaired muscle spindle function in murine models of muscular dystrophy
10.1113/jp278563 · 2020
The enzymatic processing of α-dystroglycan by MMP-2 is controlled by two anchoring sites distinct from the active site
10.1371/journal.pone.0192651 · 2018
Animal models for researching approaches to therapy of Duchenne muscular dystrophy
10.1007/s11248-021-00278-3 · doi-reference
Regulation of matrix metalloproteinase gene expression
10.1002/jcp.20948 · doi-reference
Schwann cell interactions during the development of the peripheral nervous system
10.1002/dneu.22744 · doi-reference
Increased mRNA expression of tissue inhibitors of metalloproteinase-1 and -2 in Duchenne muscular dystrophy
10.1007/s00401-004-0941-0 · doi-reference
Insights into the regulation of protein abundance from proteomic and transcriptomic analyses
10.1038/nrg3185 · doi-reference
The influence of visual and tactile perception on hand control in children with Duchenne muscular dystrophy
10.1111/dmcn.12469 · doi-reference
The shortest isoform of dystrophin (Dp40) interacts with a group of presynaptic proteins to form a presumptive novel complex in the mouse brain
10.1007/s12035-012-8233-5 · doi-reference
Histomorphology of neuromuscular junction in Duchenne muscular dystrophy
10.1111/j.1460-9592.2008.02411.x · doi-reference
Proteolytic and non-proteolytic roles of membrane type-1 matrix metalloproteinase in malignancy
10.1016/j.bbamcr.2009.04.009 · doi-reference
Two isoforms of glutamate decarboxylase: why?
10.1016/s0165-6147(98)01270-x · doi-reference
The molecular basis of muscular dystrophy in the mdx mouse: a point mutation
10.1126/science.2662404 · doi-reference
Specific disruption of a Schwann cell dystrophin-related protein complex in a demyelinating neuropathy
10.1016/s0896-6273(01)00327-0 · doi-reference
Muscular fatigue in Duchenne muscular dystrophy
10.1212/wnl.45.2.306 · doi-reference
Expression and function of GABA receptors in myelinating cells
10.3389/fncel.2020.00256 · doi-reference
Metabolism and functions of lipids in myelin
10.1016/j.bbalip.2014.12.016 · doi-reference
Recent progress on the molecular organization of myelinated axons
10.1046/j.1529-8027.2002.02001.x · doi-reference
Unique role of dystroglycan in peripheral nerve myelination, nodal structure, and sodium channel stabilization
10.1016/s0896-6273(03)00301-5 · doi-reference
The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review
10.1186/s13023-017-0631-3 · doi-reference
The proprioceptive senses: their roles in signaling body shape, body position and movement, and muscle force
10.1152/physrev.00048.2011 · doi-reference
GABA-B receptors in the PNS have a role in Schwann cells differentiation?
10.3389/fncel.2012.00068 · doi-reference
Recovery of altered neuromuscular junction morphology and muscle function in mdx mice after injury
10.1007/s00018-014-1663-7 · doi-reference
Pre- and postsynaptic changes in the neuromuscular junction in dystrophic mice
10.3389/fphys.2015.00252 · doi-reference
Notch signal mediates the cross-interaction between M2 muscarinic acetylcholine receptor and neuregulin/ErbB pathway: effects on Schwann cell proliferation
10.3390/biom12020239 · doi-reference
Terminal Schwann cell structure is altered in diaphragm of mdx mice
10.1002/mus.20405 · doi-reference
Complexity of skeletal muscle degeneration: multi-systems pathophysiology and organ crosstalk in dystrophinopathy
10.1007/s00424-021-02623-1 · doi-reference
Opposing extracellular signal–regulated kinase (ERK) and Akt pathways control Schwann cell myelination
10.1523/jneurosci.5520-03.2004 · doi-reference
Both laminin and Schwann cell dystroglycan are necessary for proper clustering of sodium channels at nodes of Ranvier
10.1523/jneurosci.2068-05.2005 · doi-reference
Recent insights into neuromuscular junction biology in Duchenne muscular dystrophy: impacts, challenges, and opportunities
10.1016/j.ebiom.2020.103032 · doi-reference
Bringing nerve excitability out of the research laboratory into the clinic
10.1016/j.cnp.2022.10.001 · doi-reference
Myelination of the nervous system: mechanisms and functions
10.1146/annurev-cellbio-100913-013101 · doi-reference
Phosphorylation of serine residues 3, 6, 10, and 13 distinguishes membrane anchored from soluble glutamic acid decarboxylase 65 and is restricted to glutamic acid decarboxylase 65alpha
10.1074/jbc.272.3.1548 · doi-reference
Dystrophin Dp71 and the neuropathophysiology of Duchenne muscular dystrophy
10.1007/s12035-019-01845-w · doi-reference
Serum matrix metalloproteinase-9 (MMP-9) as a biomarker for monitoring disease progression in Duchenne muscular dystrophy (DMD)
10.1016/j.nmd.2011.05.011 · doi-reference
Axonal neuregulin-1 regulates myelin sheath thickness
10.1126/science.1095862 · doi-reference
Decreased electrical excitability of peripheral nerves in demyelinating polyneuropathies
10.1136/jnnp.62.4.398 · doi-reference
Src and phospho-FAK kinases are activated by allopregnanolone promoting Schwann cell motility, morphology and myelination
10.1111/jnc.13951 · doi-reference
Neuregulin-ERBB signaling in the nervous system and neuropsychiatric diseases
10.1016/j.neuron.2014.06.007 · doi-reference
Modeling the excitability of mammalian nerve fibers: influence of afterpotentials on the recovery cycle
10.1152/jn.00353.2001 · doi-reference
Dystrophin Dp116: a yet to be investigated product of the Duchenne muscular dystrophy gene
10.3390/genes8100251 · doi-reference
Differential expression of dystrophin, utrophin and dystrophin-associated proteins in peripheral nerve
10.1016/0014-5793(93)80695-q · doi-reference